Hypertropic Cardiomyopathy – Pipeline Review, H2 2012

Publisher Name :
Date: 31-Oct-2012
No. of pages: 32
Inquire Before Buying

Hypertropic Cardiomyopathy – Pipeline Review, H2 2012

Summary

Global Markets Direct’s, ‘Hypertropic Cardiomyopathy – Pipeline Review, H2 2012′, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Hypertropic Cardiomyopathy, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hypertropic Cardiomyopathy. Hypertropic Cardiomyopathy – Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Hypertropic Cardiomyopathy.
- A review of the Hypertropic Cardiomyopathy products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Hypertropic Cardiomyopathy pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Hypertropic Cardiomyopathy.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Hypertropic Cardiomyopathy pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Hypertropic Cardiomyopathy – Pipeline Review, H2 2012

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Hypertropic Cardiomyopathy Overview 6
Therapeutics Development 7
An Overview of Pipeline Products for Hypertropic Cardiomyopathy 7
Hypertropic Cardiomyopathy Therapeutics under Development by Companies 9
Hypertropic Cardiomyopathy Therapeutics under Investigation by Universities/Institutes 10
Late Stage Products 11
Comparative Analysis 11
Mid Clinical Stage Products 12
Comparative Analysis 12
Hypertropic Cardiomyopathy Therapeutics - Products under Development by Companies 13
Hypertropic Cardiomyopathy Therapeutics - Products under Investigation by Universities/Institutes 14
Companies Involved in Hypertropic Cardiomyopathy Therapeutics Development 15
Novartis AG 15
Hypertropic Cardiomyopathy - Therapeutics Assessment 16
Assessment by Monotherapy Products 16
Assessment by Route of Administration 17
Assessment by Molecule Type 19
Drug Profiles 21
ARRY-162 - Drug Profile 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
perhexiline - Drug Profile 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
diltiazem hydrochloride - Drug Profile 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
atorvastatin calcium - Drug Profile 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
losartan potassium - Drug Profile 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
losartan potassium - Drug Profile 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
Hypertropic Cardiomyopathy Therapeutics - Drug Profile Updates 29
Hypertropic Cardiomyopathy Therapeutics - Dormant Products 30
Appendix 31
Methodology 31
Coverage 31
Secondary Research 31
Primary Research 31
Expert Panel Validation 31
Contact Us 32
Disclaimer 32

List of Tables
Number of Products Under Development for Hypertropic Cardiomyopathy, H2 2012 7
Products under Development for Hypertropic Cardiomyopathy - Comparative Analysis, H2 2012 8
Number of Products under Development by Companies, H2 2012 9
Number of Products under Investigation by Universities/Institutes, H2 2012 10
Comparative Analysis by Late Stage Development, H2 2012 11
Comparative Analysis by Mid Clinical Stage Development, H2 2012 12
Products under Development by Companies, H2 2012 13
Products under Investigation by Universities/Institutes, H2 2012 14
Novartis AG, H2 2012 15
Assessment by Monotherapy Products, H2 2012 16
Assessment by Stage and Route of Administration, H2 2012 18
Assessment by Stage and Molecule Type, H2 2012 20
Hypertropic Cardiomyopathy Therapeutics - Drug Profile Updates 29
Hypertropic Cardiomyopathy Therapeutics - Dormant Products 30

List of Figures
Number of Products under Development for Hypertropic Cardiomyopathy, H2 2012 7
Products under Development for Hypertropic Cardiomyopathy - Comparative Analysis, H2 2012 8
Products under Development by Companies, H2 2012 9
Products under Investigation by Universities/Institutes, H2 2012 10
Late Stage Products, H2 2012 11
Mid Clinical Stage Products, H2 2012 12
Assessment by Monotherapy Products, H2 2012 16
Assessment by Route of Administration, H2 2012 17
Assessment by Stage and Route of Administration, H2 2012 18
Assessment by Molecule Type, H2 2012 19
Assessment by Stage and Molecule Type, H2 2012 20

  • Global Dental Implants Market Driven by Demand in Cosmetic Dentistry
    The global market for dental implants has been witnessing steady growth in the last couple of years due to increased demand for cosmetic dentistry and rise in incidences of dental disorders. People’s awareness about aesthetic dentistry procedures has increased in recent years, which is also fueling the growth of the dental implant market. With economic [...]
  • Air Traffic Management and Control Market Driven by Technological Advancement
    The global market for air traffic management and control has grown steadily in the last couple of years with increase in air traffic volume and congestion. Air Traffic Control (ATC) consists of an elaborate system of ground stations, radar arrays and professional air traffic controllers. With increase in air travel for business and leisure, as [...]
  • Global Stem Cell Therapy Industry Witnesses Steady Growth
    Stem cell research which is one of the most contemporary areas of biology has developed rapidly in the last couple of years. Increased funding in stem cell research by both government and private organizations is one of the main drivers in the stem cell therapy industry. Stem cells are used in various medical therapies such [...]
  • Global Lubricant Market Driven by Increased Demand in Automotive Industry
    With growth in the automobile industry, the demand for lubricants has also increased. The robust growth in manufacturing with increase in industrial production, particularly in countries such as China and India are also fueling the demand for lubricants. In 2013, the global market for lubricants had reached a value of 123.64 billion USD. By 2020, [...]
  • Global Cybersecurity Market Driven by Increase in Cyber Attacks
    In recent years, the global market for cybersecurity has grown steadily, with the rapid adoption of cloud-based services. As more and more corporate and government organizations are realizing the importance of protecting data and intellectual property, the market for cybersecurity is going to expand. In 2014, the global market for cybersecurity was valued at 95.60 [...]
  • Graft-Versus-Host Disease (GVHD) Treatment Market worth $407 million by 2018
  • The graft-versus-host disease (GVHD) treatment market value will increase from $297 million in 2013 to $407 million by 2018, at a Compound Annual Growth Rate (CAGR) of 6.59%, according to research and consulting firm GlobalData. The company’s latest report* states …

  • Poland Pharmaceutical Industry Growing at 8.3% CAGR to 2020
  • Factors such as the growing elderly population, increasing availability of affordable medicines, and transparent regulatory guidelines will provide the necessary impetus for the growth of the Polish pharmaceutical market, but a decrease in mark-up prices and the country’s stringent drug …

  • Asia-Pacific, Led by China, Drive the Global Methanol Industry
  • China is driving the global methanol industry, with tremendous demand from both its energy and petrochemicals sectors. It accounts for 87.9% of Asia-Pacific’s (APAC) methanol capacity, and 51.9% of the global methanol capacity. Despite a large planned capacity increase in …

  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • Empty Capsules Market by Product (Hard gelatin, Non-gelatin capsules), Raw Material (Pig meat, Bovine, HPMC), Therapeutic Application (Antibiotics, Vitamins) & by End User (Pharmaceutical, Health Supplements) – Global Forecast to 2019
    Published: 26-Nov-2014        Price: US $4650 Onwards        Pages: 210
    Over the last decade, the empty capsules market is experiencing growth primarily due to the rising aging population and technological innovations in the empty capsules market. The fast-growing pharmaceutical and nutraceutical industries are catalyzing the growth of the empty capsules market. In this report, the global empty capsules market is segmented by products, source of raw materials, therapeutic applications, and end users. The empty capsules products market is segmented into hard gelat......
  • 2014 Market Research Report on Global Insulin Industry
    Published: 26-Nov-2014        Price: US $2200 Onwards        Pages: 139
    This is a professional and depth research report on Global Insulin industry. For overview analysis, the report introduces Insulin basic information including definition, classification, application, industry chain structure, industry overview, policy analysis, and news analysis, etc. For international and China market analysis, the report analyzes Insulin markets in China and other countries or regions (such as US, Europe, Japan, etc) by presenting research on global products of different ......
  • Argentina Pharmaceuticals and Healthcare Report Q1 2015
    Published: 26-Nov-2014        Price: US $1295 Onwards        Pages: 135
    BMI View: We expect increasing competitive pressure in the Argentine pharmaceutical sector as South- South relations continue to develop. This is illustrated by the Argentine government recent authorization for Indian pharmaceutical firms to export finished formulations to Argentina. Argentina's debt default poses downside risk to economic activity in the next quarters, while we expect inflation and drug pricing controls to continue hampering the pharmaceutical market potential. The challeng......
  • Botswana Pharmaceuticals and Healthcare Report Q1 2015
    Published: 26-Nov-2014        Price: US $1295 Onwards        Pages: 63
    BMI View: Our outlook for the pharmaceutical and healthcare markets of Botswana is reasonably positive due to the government's increasing commitment to improve the country's healthcare sector. The country's import reliance for pharmaceuticals, coupled with the forecast depreciation of the Botswana pula will be seen as a negative for the local industry as imports will become increasingly expensive. Headline Expenditure Projections ? Pharmaceuticals: BWP1.66bn (USD198mn) in 2013 to BWP1.85bn ......
  • Cameroon Pharmaceuticals and Healthcare Report Q1 2015
    Published: 26-Nov-2014        Price: US $1295 Onwards        Pages: 56
    BMI View: Against a backdrop of sustained economic growth, Cameroon's pharmaceuticals and healthcare market will sustain an expansive trajectory over the medium-to-long term. Although from a low per-capita spending level, population growth and rising incomes will drive drug consumption in the foreseeable future. A number of public and private investment projects across the healthcare system will contribute to overall sector growth, as illustrated by recent investment projects by Swiss entrep......
  • Mozambique Pharmaceuticals and Healthcare Report Q1 2015
    Published: 26-Nov-2014        Price: US $1295 Onwards        Pages: 52
    BMI View: Mozambique has a fast-growing economy thanks to its natural resources and agricultural industry. The Mozambican government continues to show its commitment towards the development of healthcare infrastructure by tackling the country's shortages of health professionals and clinic with the aid of foreign investors. However, barriers to investment remain, including high levels of corruption and lowlevel political instability, working against market growth. Headline Expenditure Foreca......
  • Singapore Pharmaceuticals and Healthcare Report Q1 2015
    Published: 26-Nov-2014        Price: US $1295 Onwards        Pages: 133
    BMI View: Driven by a rapidly ageing population and growing government health expenditure, Singapore's pharmaceutical sales will continue its steady growth over the next decade. This growth is only constrained by its small population. The country's high levels of education, strong patent protection and good infrastructure also makes it a highly competitive location for international pharmaceutical companies to establish research and development and manufacturing facilities as the region inte......
  • Global Pregnancy Detection Kit Market 2015-2019
    Published: 26-Nov-2014        Price: US $2500 Onwards        Pages: 78
    Pregnancy detection kits are diagnostic products that check for chemical markers related to pregnancy. These kits take up the midstream format, which is one of the three categories under rapid pregnancy tests. The remaining two are the strip format and the card or cassette format. A pregnancy detection kit uses rapid chromatographic immunoassay technique for the detection of hCG in urine to indicate pregnancy. Although these detection kits are available to both the OTC and professional markets, ......
  • Global Pulse Oximetry Market 2015-2019
    Published: 26-Nov-2014        Price: US $2500 Onwards        Pages: 66
    Pulse oximetry is a non-invasive method used to measure the arterial oxygen saturation level in patient's blood. Pulse oximetry works on the principle of spectrophotometry. The technique makes use of characteristics of hemoglobin for absorption of light and the pulsating nature of blood flow in the arteries. Using a pulse oximeter, hypoxia (a condition in which there is an inadequate oxygen supply in the body or a region of the body) can be detected before patients become cyanosed clinically. Pu......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs